The Current Scenario of Biosimilars in Mexico

Mondaq Business BriefingMexico Law Articles in English (2010)

Linked as:

Extract


The Current Scenario of Biosimilars in Mexico

When talking about allopathic medicines, it is well known that the Pharmaceutical Industry in Mexico does not carry on research and development in primary molecules but only on secondary molecules, i.e. form...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex Mexico

Explore vLex

For Professionals

For Partners

Company